We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Muscarinic Effects of Clozapine and Negative Symptoms

M. Keshavan, MD
Arch Gen Psychiatry. 1993;50(10):835. doi:10.1001/archpsyc.1993.01820220091014.
Text Size: A A A
Published online


Tandon and Kane1 provide a thoughtful review of the neuropharmacological profile of the atypical antipsychotic drug, clozapine, in the February 1993 issue of the ARCHIVES. They propose that the in vivo partial agonist effect of clozapine may be relevant for the beneficial effect of clozapine in the treatment of patients with refractory schizophrenia. They derive support for this possibility from the cholinergic-dopaminergic imbalance model of schizophrenia wherein an overactive muscarinic system may diminish the expression of positive psychotic symptoms presumably caused by dopaminergic hyperfunction.2 Other pharmacological evidence not reviewed by the authors also supports a role for the muscarinic system in the atypical therapeutic effects of clozapine; muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.3

Although the cholinergic-dopaminergic model adequately explains the therapeutic effect of clozapine on positive symptoms, it does not explain improvement of negative symptoms.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.